NewsRx

Search our medical news database

Breast Implants

Implants receive full European Union Class III medical device certification

Published in Women's Health Weekly, March 18th, 2004

Inamed Corp. (IMDC), a global healthcare company, was notified that it has received Class III CE Mark approval and recertification of the safety and efficacy for all its breast implants that are currently distributed in the European Union.

This includes the McGhan and CUI brand single lumen silicone gel-filled breast implants, double lumen silicone gel/saline breast implants, and saline breast implants.

"We appreciate the European Union regulatory authorities acting favorably to recertify the entire range of our breast implant products for continued distribution throughout the E.U.," said Nick Teti, chairman, president, and CEO of Inamed Corp. "The...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook